Sales Desk – US 877.701.2883
Sales Desk – International +353 1 525 9677
Sales Desk – US 877.701.2883
Sales Desk – International +353 1 525 9677
I love this ‘damnable’ bank stock: Fund manager By Matthew J. Belvedere For more information go to www.cnbc.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future
Squawk Box hosted by Becky Quick, Andrew Ross Sorkin, Joe Kernan On Oil On PayPal On BofA The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of
Howard Gold is an inquisitive writer for Marketwatch.com and we think has done us all a great favor in his latest column titled, “Not even a bull market can interest people in stocks.” He points out via the chart below that—despite a huge rebound the last five years in US common stocks—equity holdings as a percentage of global investable assets just climbed to levels only seen at major stock market low points. Relative to the past 50 years, this stock market has been abandoned and orphaned even as it had made participants wealthy.
We at Smead Capital Management have been discussing some of the follies common to human nature and what we see as some pervasive trends in the investing world. These conversations got us imagining what C.S. Lewis’s, The Screwtape Letters, might sound like if they were applied to today’s investment environment. The satirical letters are written by an advice-giving bureaucrat in Hell named Screwtape, to his nephew Wormwood, a young demon who is learning how to lead humans astray. Taking some liberty with Lewis’s work, we present what we believe Screwtape might say if he were trying to advise Wormwood on how to lead investors astray.
Buffett’s Railroad Bonds Cheap to U.S. Peers: Corporate Finance By Charles Mead and Noah Buhayar For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no
Pfizer a Buy as it Halts Pursuit of AstraZeneca By Teresa Rivas For more information go to www.barrons.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future
At Smead Capital Management, we have our own Efficient Market Theory. Ben Graham observed and Warren Buffett repeated, “The stock market has a very efficient way of transferring wealth from the impatient to the patient.” We would add that over ten to twenty years the stock market moves money “efficiently from the those who over-think the stock market to those who don’t.” In this missive we will explain why we believe the patient benefit at the expense of the impatient and why those who over-think the stock market are incredibly inefficient and move their money to those with less complicated views on finance.
Merck Not Out for Another Big Deal, Says CEO; ‘We’re Not Serial Acquirers’ By Drew Armstrong and Michelle Fay Cortez For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment
Calstrs to Vote Against BofA Directors in Proxy Campaign By Julie Steinberg and Christina Rexrode For more information go to www.online.wsj.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no
Pfizer expected to be patient in face of AstraZeneca rejection By Bill Berkrot For more information go to www.reuters.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of
Which fund do you want to go to?
Smead Value FundSmead International Value Fund
take me back